Literature DB >> 16333594

Right ventricular cardiac myxoma. Diagnostic usefulness of cardiac magnetic resonance imaging.

Peter Alter1, Wolfram Grimm, Marga B Rominger, Michael Ritter, Klaus J Klose, Rainer Moosdorf, Bernhard Maisch.   

Abstract

BACKGROUND: Cardiac myxomas are the most common type of cardiac tumors. About 75-85% of cardiac myxomas originate in the left atrium, 15-20% in the right atrium. Most myxomas arise from the interatrial septum adjacent to the fossa ovalis. Only 3-4% are found in the left and right ventricle each. Although myxomas are histologically benign, they may be fatal because of their strategic position. CASE STUDY: The authors report on a 24-year-old patient with stabbing thoracic pain and dyspnea due to pulmonary thromboembolism that was caused by an atypically localized myxoma at the right ventricular apex originating from the interventricular septum. The diagnosis was based on cardiac magnetic resonance (CMR) imaging. Superior to echocardiography, CMR could strengthen the diagnostic accuracy by additional information on tissue characterization using different imaging sequences. Typically for cardiac myxomas, contrast enhancement was moderate and delayed enhancement was found in the outer circumferential tumor margins only.
CONCLUSION: High spatial resolution and multiplane imaging combined with different acquisition patterns of CMR achieve a global view of the heart that seems to be useful for diagnosing cardiac tumorous masses.

Entities:  

Mesh:

Year:  2005        PMID: 16333594     DOI: 10.1007/s00059-005-2668-7

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  2 in total

1.  MRI: more than meets the echo eye.

Authors:  Mi-Seung Shin; Yon Mi Sung; Bong Roung Kim
Journal:  Int J Cardiovasc Imaging       Date:  2010-02-24       Impact factor: 2.357

2.  23-year experience on diagnosis and surgical treatment of benign and malignant cardiac tumors.

Authors:  Anna Kośmider; Ryszard Jaszewski; Anna Marcinkiewicz; Karol Bartczak; Jerzy Knopik; Stanisław Ostrowski
Journal:  Arch Med Sci       Date:  2013-11-05       Impact factor: 3.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.